Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
about
Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanismsThe structure of Rap1 in complex with RIAM reveals specificity determinants and recruitment mechanismMechanoinduction of lymph vessel expansion.A genome-wide DNA methylation study in colorectal carcinoma.Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.Integrin-α5β1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation.Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.Abl-interactor-1 (Abi1) has a role in cardiovascular and placental development and is a binding partner of the alpha4 integrin.Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Cell Adhesion Mediated by VCAM-ITGα9 Interactions Enables Lymphatic DevelopmentGap junction coupling is required for tumor cell migration through lymphatic endotheliumBiomarkers as key contributors in treating malignant melanoma metastases.EILDV-conjugated, etoposide-loaded biodegradable polymeric micelles directing to tumor metastatic cells overexpressing α4β1 integrinAnti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinomaIntegrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasisTumor lymphangiogenesis as a potential therapeutic target.Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesisFibronectin-α4β1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway.Lactoferrin regulates an axis involving CD11b and CD49d integrins and the chemokines MIP-1α and MCP-1 in GM-CSF-treated human primary eosinophils.TSC2 modulates cell adhesion and migration via integrin-α1β1The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.Netrin-4 activates endothelial integrin {alpha}6{beta}1.Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy.Structural and Functional Analysis of a Talin Triple-Domain Module Suggests an Alternative Talin Autoinhibitory ConfigurationPI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes.Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins.Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic functionGenetic analyses of integrin signaling.Mechanical forces in lymphatic vascular development and disease.Lymphangiogenesis and lymphatic vessel remodelling in cancer.Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis.The novel α4B murine α4 integrin protein splicing variant inhibits α4 protein-dependent cell adhesion.Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.A longitudinal MRI study on lymph nodes histiocytosis of a xenograft cancer model.Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
P2860
Q26830901-94C90368-102A-4136-A6EE-4E620299B5A8Q27680703-EF66C07A-F2E9-448D-ABED-C408A42C2160Q30505376-F2339863-D596-41CA-9207-60E694EE0AD2Q31020320-6BBB508F-88FA-44A4-A0BB-928A2C67F9FAQ33563488-C1D1F6F2-C25C-43B1-9B0A-01BE0A551519Q33963025-380ACCB2-F025-49F7-9D80-4E9C31A068D9Q34326240-B309EDC2-CC2F-4A9A-91F2-0F91A65E1757Q34472031-72CD4083-E71B-48F3-AAD8-C7B67C84E551Q34488846-D6A58CA4-2F38-4AA1-8E08-23D7BD6AD808Q34541791-AB1791F0-FAFF-4DB5-AAF7-6311FE772309Q34914039-CDDA6341-7715-4696-87B1-F56B78CB2C37Q35537280-5DD20283-B32B-406F-A718-FFBD935170F7Q35537353-B8050CC0-3309-4441-8594-C3A131F7F308Q35550888-BBB0CC0B-A301-4C2A-845D-9D95F997782AQ35673648-61488706-17B2-414E-A764-A9D1091647CDQ35741034-7DAB16C3-6240-465B-9A3C-70C9FB5F4142Q35810928-76417AD3-1000-4962-8DFB-51DE3EE251B4Q35838122-672A80E6-0602-474D-B7D5-330168F27999Q35935011-647FEEF5-4B55-4D4E-8FC7-E8513F425003Q35995835-0025D170-DA70-4D3C-9EEB-509D42FB596AQ36282336-A3F494E3-5CB5-455A-A577-7DF66BB7E085Q36296976-590D825B-C294-4A05-80D4-7178B1CCF0EEQ36312486-2C6F9DB9-8420-44BE-9603-662307282AF6Q36339264-33CAE1D1-00E3-40CA-AB3C-4B3EC5FD2B4CQ36555407-9F4D856D-2762-4E20-A742-C70D0D1F237AQ36677180-F2627F4B-7517-424E-86F0-D53FB5048910Q36880854-C0A93D14-B859-45CE-A544-FEDE5BF38041Q36895525-D8DA4BA4-D174-42B1-B716-D2CA11917431Q37364878-11DD6421-F77E-4403-87A0-34CE126BAD8AQ37373141-6C8C0412-08C3-442B-A195-B1BC81803D0DQ37499263-89EA9735-2EB3-4389-916F-11669E54DF0EQ37781426-031DBD6C-634A-4AF1-B09A-94B208819A18Q37855339-4274FF48-E80B-4519-B787-2698A22FE222Q38105904-E677D982-53CB-4621-83BA-FE30478D73B9Q38190359-C34BDDB2-380E-4BEE-BEE5-6F58EE84EDF9Q38207560-43825679-F8F2-4B6D-A298-2BCE7BFF0CE4Q38307621-3450A441-83A6-4CB3-9EE2-82AC166A6049Q38309552-DEEED85B-281D-4F4D-85FB-D8548ED923E4Q38697440-E8580CAE-4EC5-407C-B2DD-ADD7B87094DEQ38839716-6030FB14-BA05-4FFC-95CD-0F740416A093
P2860
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
@ast
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
@en
type
label
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
@ast
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
@en
prefLabel
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
@ast
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
@en
P2093
P2860
P50
P1433
P1476
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis
@en
P2093
Andrew Lowy
Christie J Avraamides
David Cheresh
Judith A Varner
Leo Barnes
Lesley G Ellies
Mark Ginsberg
Philippe Foubert
Sarah L Blair
Thalia Papayannopoulou
P2860
P304
P356
10.1158/0008-5472.CAN-09-3761
P407
P577
2010-04-13T00:00:00Z